FDA Inspection 1261674 — Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant)
The FDA completed an inspection of Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant) on March 14, 2025 in Wenzhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 14, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Wenzhou (China)